lacosamide ucb
ucb pharma s.a. - lacosamide - epilepsies, partial - antiepileptics, - lacosamide ucb is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.,
neupro
ucb australia pty ltd t/a ucb pharma division of ucb australia - rotigotine -
vimpat
ucb australia pty ltd t/a ucb pharma division of ucb australia - lacosamide -
swab
ucb australia pty ltd t/a ucb pharma division of ucb australia - 13912 - swab - alcohol swab to clean area prior to injecting.
elantan 20 milligram tablets
ucb (pharma) ireland limited - isosorbide mononitrate - tablets - 20 milligram
elantan 10 milligram tablets
ucb (pharma) ireland limited - isosorbide mononitrate - tablets - 10 milligram
elantan 40 mg tablets 40 milligram tablets
ucb (pharma) ireland limited - isosorbide mononitrate - tablets - 40 milligram
elantan la 25 milligram prolonged release capsules
ucb (pharma) ireland limited - isosorbide mononitrate - prolonged release capsules - 25 milligram
elantan la hard 50 milligram prolonged release capsules
ucb (pharma) ireland limited - isosorbide mononitrate - prolonged release capsules - 50 milligram
isoket 0.05 %w/v solution for infusion
ucb pharma limited - isosorbide dinitrate - solution for infusion - 0.05 %w/v